Romiplostim Injection Uses, Dosage, Side Effects and Interactions
Nplate
Nplate is a brand of romiplostim injection that comes as an injection.
Romiplostim is an injectable medication that boosts platelet production, used to treat low platelet counts in immune thrombocytopenia (ITP) and to improve survival after life-threatening radiation exposure.
Quick links
Ask Anything About Romiplostim InjectionType a question in your own words. Answered from its FDA label in seconds.Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.
Romiplostim Injection in Short
- Drug class Thrombopoietin Receptor Agonist How the FDA classifies it
What it treatsNplate (romiplostim) injection is used to treat immune thrombocytopenia (ITP) — a condition where the immune system destroys platelets, leaving counts too low and raising the risk of serious bleeding.
- How you get it Prescription only
- Comes asInjection (under the skin)
- Important safety informationWarnings and precautions Read the warnings and precautions for your exact product.
The Pharmacist’s Take
Nplate (romiplostim) mimics thrombopoietin, the body’s own platelet-signaling protein, so the bone marrow makes more platelets; it is a well-established next step for immune thrombocytopenia (ITP) after steroids, immunoglobulins or spleen removal fall short, on the market since about 2008 with no generic available, and it is also given once to improve survival after severe radiation exposure. Most people tolerate it well, and headache, joint or muscle pain and dizziness are the side effects people notice most. The serious risk is blood clots, which is why the aim is a platelet count high enough to protect against bleeding, never a normal count.
Key Takeaways From the HelloPharmacist Team
- Expect an injection under the skin once a week, with a platelet count check guiding each week’s dose until it is stable.
- Get emergency help for chest pain, shortness of breath or coughing up blood, and call promptly about sudden leg pain, swelling or redness.
- Keep listing every ITP medicine you use, such as steroids, IVIG or danazol, since these can generally be combined with it.
Patient Information Guide for Romiplostim Injection
What It’s Used For
Romiplostim (Nplate injection) is approved for two distinct situations involving dangerously low platelet counts:
- Immune thrombocytopenia (ITP) in adults: Nplate treats low platelets caused by the immune system when previous treatments — including corticosteroids, immunoglobulins, or spleen removal — have not worked well enough.
- ITP in children (1 year and older): Nplate treats ITP in pediatric patients who have had the condition for at least 6 months and have not responded sufficiently to standard therapies.
- Hematopoietic Syndrome of Acute Radiation Syndrome (HS-ARS): Nplate is used to increase survival in adults and children — including newborns — who have been exposed to radiation doses high enough to suppress bone marrow function.
- Important limits: Nplate is not approved for low platelets caused by myelodysplastic syndrome (MDS) or any other cause besides ITP. It should only be used when low platelet counts increase bleeding risk — not to normalize counts.
How It Works
Romiplostim works by binding to and switching on the body's thrombopoietin (TPO) receptor — the same receptor that the body's own platelet-stimulating protein, thrombopoietin, targets. Activating this receptor signals the bone marrow to ramp up platelet production. This leads to a higher platelet count in the blood, which helps protect against abnormal bleeding. The effect mimics what the body would naturally do if it were producing enough thrombopoietin on its own.
Because the drug is cleared partly through the TPO receptors on platelets themselves, patients with very low platelet counts may have higher drug levels in the blood, while those with higher counts may have lower levels. This is why dose adjustments based on platelet count monitoring are so important.
Drug Class
Drug Class
- Thrombopoietin Receptor Agonist
Detailed classifications and sources
The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class.
Drug Class
Established Pharmacologic Class (EPC)- Thrombopoietin Receptor Agonist
The main drug class the FDA gives it. It is the class named on the drug’s label.
How It Works
Mechanism of action (MoA)- Thrombopoietin Receptor Agonists
What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.
What It Does in the Body
Physiologic effect (PE)- Increased Megakaryocyte Maturation
- Increased Platelet Production
A change it makes in how the body works.
Chemical Family
Chemical structure (CS)None listed for Romiplostim Injection in the FDA’s index.
The chemical family it belongs to, by its structure.
Drug Family
WHO ATC classification- Other systemic hemostatics
How the World Health Organization groups it: by the part of the body it acts on and what it treats.
The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.
Dosage
Nplate is given as a subcutaneous (under the skin) injection — never by mouth or intravenously. For ITP, it is injected once a week, and the dose is carefully adjusted based on how your platelet count responds.
Your doctor will check your blood counts weekly during dose adjustments, then monthly once the dose is stable.
- For radiation exposure (HS-ARS), Nplate is given as a single injection as soon as possible after exposure — no weekly schedule is used in this setting.
- The injection volume can be very small, so a specially calibrated syringe (with 0.01 mL markings) is required for accurate dosing.
- Always follow your prescriber's instructions on dose and timing — do not adjust on your own.
Typical Doses
Your prescriber chooses your dose, so take it exactly as prescribed.
Immune thrombocytopenia (ITP, low platelet counts)
Adults · Starting dose Starting dose 1 mcg/kg once a week
- 1 mcg/kg once weekly as a subcutaneous injection, using actual body weight at initiation of treatment
Adults · Dose adjustment Highest dose 10 mcg/kg once a week
- Adjust the weekly dose by increments of 1 mcg/kg until platelet count is ≥ 50 × 10 9 /L
- If platelet count is < 50 × 10 9 /L, increase by 1 mcg/kg
- If > 200 × 10 9 /L and ≤ 400 × 10 9 /L for 2 consecutive weeks, reduce by 1 mcg/kg
- If > 400 × 10 9 /L, do not dose, then resume at a dose reduced by 1 mcg/kg after platelet count falls to < 200 × 10 9 /L
Good to know
Dose changes in adults are based on platelet counts only
Children 1 year old and older · Starting dose Starting dose 1 mcg/kg once a week
- 1 mcg/kg once weekly as a subcutaneous injection, using actual body weight at initiation of treatment
Children 1 year old and older · Dose adjustment Highest dose 10 mcg/kg once a week
- Adjust the weekly dose by increments of 1 mcg/kg until platelet count is ≥ 50 × 10 9 /L
- If platelet count is < 50 × 10 9 /L, increase by 1 mcg/kg
- If > 200 × 10 9 /L and ≤ 400 × 10 9 /L for 2 consecutive weeks, reduce by 1 mcg/kg
- If > 400 × 10 9 /L, do not dose, then resume at a dose reduced by 1 mcg/kg after platelet count falls to < 200 × 10 9 /L
Good to know
Adjustments are based on platelet counts and body weight; reassess body weight every 12 weeks
These are the doses for children. For adults, see “Immune thrombocytopenia (ITP, low platelet counts).”
Radiation exposure that harms the bone marrow (acute radiation syndrome)
For adults and children, including term newborns
Usual dose 10 mcg/kg once
- 10 mcg/kg administered once as a subcutaneous injection, as soon as possible after suspected or confirmed exposure to radiation levels greater than 2 gray (Gy)
Good to know
Give regardless of whether a complete blood count can be obtained
Vial preparation, calculated dose greater than or equal to 23 mcg (125 mcg vial)
Calculated dose of 23 mcg or more · 500 mcg/mL (1) Dose 500 mcg/mL
- Reconstitute with 0.44 mL Sterile Water for Injection
- No saline dilution required
- Final concentration 500 mcg/mL
Calculated dose of 23 mcg or more · 500 mcg/mL (2) Dose 500 mcg/mL
- Reconstitute with 0.72 mL Sterile Water for Injection
- No saline dilution required
- Final concentration 500 mcg/mL
Calculated dose of 23 mcg or more · 500 mcg/mL (3) Dose 500 mcg/mL
- Reconstitute with 1.2 mL Sterile Water for Injection
- No saline dilution required
- Final concentration 500 mcg/mL
Vial preparation, calculated dose less than 23 mcg (125 mcg vial)
For calculated dose under 23 mcg
Dose 125 mcg/mL
- Reconstitute with 0.44 mL Sterile Water for Injection, then dilute with 1.38 mL 0.9% Sodium Chloride Injection
- Final concentration 125 mcg/mL
Vial preparation, calculated dose less than 23 mcg (250 mcg vial)
For calculated dose under 23 mcg
Dose 125 mcg/mL
- Reconstitute with 0.72 mL Sterile Water for Injection, then dilute with 2.25 mL 0.9% Sodium Chloride Injection
- Final concentration 125 mcg/mL
Vial preparation, calculated dose less than 23 mcg (500 mcg vial)
For calculated dose under 23 mcg
Dose 125 mcg/mL
- Reconstitute with 1.2 mL Sterile Water for Injection, then dilute with 3.75 mL 0.9% Sodium Chloride Injection
- Final concentration 125 mcg/mL
Volume to administer, calculated dose greater than or equal to 23 mcg
For calculated dose of 23 mcg or more
Dose 500 mcg/mL
- Calculated Patient Dose / 500 mcg/mL (mL)
Good to know
Round volume to the nearest hundredth mL
Volume to administer, calculated dose less than 23 mcg
For calculated dose under 23 mcg
Dose 125 mcg/mL
- Calculated Patient Dose / 125 mcg/mL (mL)
Good to know
Round volume to the nearest hundredth mL
Side Effects
The most commonly reported side effects with Nplate include:
Common side effects
- Joint pain (arthralgia)
- Muscle pain (myalgia)
- Headache
- Dizziness
- Trouble sleeping (insomnia)
- Stomach pain
- Pain in the arms or legs
- Tingling or numbness (paresthesia)
- In children: bruising (contusion), upper respiratory infections, and sore throat (oropharyngeal pain) are very common
When to get medical help
- Call your doctor if you have sudden leg pain, swelling, or redness — these can be signs of a blood clot (deep vein thrombosis)
- Get emergency help for chest pain, shortness of breath, or coughing up blood — possible signs of a pulmonary embolism or heart attack
- Tell your doctor right away about upper right stomach pain or swelling — this may signal portal vein thrombosis (a clot in the liver's vein)
- Contact your doctor if your platelet count stops responding or drops despite treatment — the drug may no longer be working
- Watch for signs of bone marrow changes if you are on long-term therapy — your doctor may monitor with bone marrow tests
More serious reactions — including blood clots, signs of bone marrow changes, or a loss of drug response over time — require prompt medical attention. If you notice sudden leg swelling, chest pain, or shortness of breath, seek emergency care right away.
Warnings and Precautions
- Blood clots: Nplate can cause platelet counts to rise too high, leading to dangerous clots in veins or arteries — including in the legs, lungs, heart, brain, and the portal vein in the liver. This risk exists even at platelet counts that don't look alarming. Nplate should never be used to push platelet counts to a normal level.
- Risk of leukemia in MDS patients: Nplate must not be used for low platelets caused by myelodysplastic syndrome (MDS). In MDS patients, Nplate has been associated with an increased risk of progression to acute myelogenous leukemia (AML), a serious blood cancer.
- Bone marrow fibrosis: Long-term use may cause increased reticulin fiber or collagen formation in the bone marrow. This has been seen in both adults and children on extended therapy. Your doctor may monitor for this over time.
- Loss of response: If the drug stops working — for example, if your platelet counts no longer respond — the cause may be antibodies forming against romiplostim. Nplate will be discontinued if counts don't improve after 4 weeks at the maximum dose.
- Rebound low platelets after stopping: Blood counts should be monitored weekly for at least 2 weeks after stopping Nplate, as platelet counts may drop significantly.
Interactions
Nplate has limited known drug interactions, but it is often used alongside other ITP medications — your doctor should know everything you take:
- Corticosteroids, danazol, azathioprine, IVIG, and anti-D immunoglobulin: Nplate can be used with these standard ITP treatments, but platelet counts must be monitored closely to avoid levels that become too high and increase clot risk.
Interactions Listed in the FDA-Approved Label
From the Romiplostim Injection prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.
-
Other medical ITP therapies (corticosteroids, danazol, azathioprine, intravenous immunoglobulin (IVIG), anti-D immunoglobulin)What happensNplate may be used with other medical ITP therapies such as these.
Read the label’s full interactions text
7 DRUG INTERACTIONS Nplate may be used with other medical ITP therapies, such as corticosteroids, danazol, azathioprine, intravenous immunoglobulin (IVIG), and anti-D immunoglobulin.
Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.
Before You Start
- MDS (myelodysplastic syndrome): Nplate is not approved for this condition and may increase the risk of progression to blood cancer — do not use it for MDS-related low platelet counts.
- Chronic liver disease: Portal vein thrombosis (a blood clot in the liver's main vein) has been reported in patients with and without liver disease — tell your doctor about any liver conditions.
- Pregnancy: Nplate may harm an unborn baby based on animal studies. Tell your doctor immediately if you are pregnant or become pregnant during treatment.
- Breastfeeding: Women should not breastfeed while using Nplate due to the potential for serious harm to the nursing infant.
- Children under 1 year: Safety and effectiveness in children under 1 year of age with ITP have not been established.
- Older adults (65+): No major differences in safety have been found compared with younger patients, but dose adjustments should be made carefully given the higher chance of other health issues or medications.
Overdose
If too much Nplate is given, platelet counts can rise excessively, which significantly increases the risk of dangerous blood clots. In that situation, Nplate would be stopped and platelet counts monitored closely. Treatment can be restarted later at an adjusted dose once counts return to a safe level — always following the prescribed dosing guidelines.
Half-Life and How Your Body Processes It
After a subcutaneous injection, romiplostim reaches peak blood levels roughly 7 to 50 hours after dosing (typically around 14 hours). Its half-life — the time for the body to clear half the drug — ranges widely from 1 to 34 days, with a median of about 3.5 days. Interestingly, how quickly the drug is cleared depends partly on how many platelets are in the blood: patients with very low platelets tend to have higher drug levels, while those with higher platelet counts clear it faster. Drug levels vary considerably from person to person and do not track linearly with the dose given. In children with ITP, blood levels fall within the same range seen in adults at similar doses, though variability is also high.
Storage
Store Nplate vials in the refrigerator at 2°C to 8°C (36°F to 46°F) in the original carton to protect from light. Do not freeze. Stored in the original carton at room temperature up to a maximum of 25°C (77°F) for a single period of up to 30 days.
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Romiplostim Injection: Pharmacist Answers to Common Questions
Quick, plain-English answers to the questions patients ask most about Romiplostim Injection — the kind of thing our pharmacy team would talk through with you at the counter.
What exactly is Nplate doing in my body?
How often will I need to get these injections?
What side effects should I actually watch out for?
Can I take my other ITP medications while using Nplate?
Is Nplate safe to use if I'm pregnant or trying to get pregnant?
What happens if I stop taking Nplate?
Is romiplostim injection available over the counter?
When was romiplostim injection first available?
What is the brand name of romiplostim injection?
What is the generic name of Nplate?
What drug class is romiplostim injection?
What strengths does romiplostim injection come in?
Where can I read the romiplostim injection prescribing information (package insert)?
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Ask Anything About Romiplostim Injection
Skip the scrolling. Ask in your own words and get an answer from Romiplostim Injection’s FDA label and our pharmacists’ own work.
Name another drug or a supplement in your question and we check both.
AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
- Sources: Romiplostim Injection’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
- Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
- Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
- Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.
More About Romiplostim Injection on HelloPharmacist
Still have a question? A licensed pharmacist answers for free, as soon as they can.Romiplostim Injection Forms and Strengths (How It Comes)
Romiplostim Injection comes in 1 dose form, the injection. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Romiplostim Injection inactive ingredients by manufacturer.
Injection
How this form is used
- Nplate is used to treat immune thrombocytopenia (ITP) in adults and children 1 year and older who have not responded well to corticosteroids, immunoglobulins, or splenectomy
- Nplate is used to increase survival in adults and children (including newborns) exposed to life-threatening, bone-marrow-suppressing doses of radiation (HS-ARS)
- Nplate is given as a subcutaneous (under the skin) injection — never by any other route
- For ITP, Nplate is injected once weekly; for radiation exposure, a single injection is given as soon as possible after exposure
- Nplate comes as a powder in single-dose vials that must be reconstituted (mixed) with Sterile Water for Injection before use — do not shake the vial, gently swirl instead
- Nplate must be administered using a syringe with 0.01 mL graduations to ensure accurate dosing; discard any unused portion and never pool leftover amounts from multiple vials
Romiplostim Injection on the U.S. Market: Products, Makers and Brands
How Romiplostim Injection appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
1 company lists 3 Romiplostim Injection product records with the FDA, mostly as injection; the earliest marketing or approval year on record is 2008. The one brand name in the directory today is Nplate; the rest are generics.
Also listed with the FDA, not a patient dose form: Unfinished injection, powder, lyophilized, for solution (3) — bulk drug substance and unfinished product sold to compounders and other manufacturers to finish, and multi-item kits. These aren’t counted in the dose-form total above.
How Widely Romiplostim Injection Is Used (Medicaid Data)
How many Romiplostim Injection prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.
How commonly is Romiplostim Injection prescribed? Of the 1,682 medications we measure, Romiplostim Injection ranks #821 by Medicaid prescriptions — more than 51% of them.
Utilization by Romiplostim Injection product
Pick a strength and form to see its own numbers. Brand and generic versions are counted together.
romiplostim 0.125 MG Injection Most dispensed
1 of 2 listed NDCs had Medicaid claims. RxNorm 2201538
romiplostim 0.25 MG Injection
1 of 2 listed NDCs had Medicaid claims. RxNorm 1728092
romiplostim 0.5 MG Injection
1 of 2 listed NDCs had Medicaid claims. RxNorm 1728097
Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.
Source: Medicaid State Drug Utilization Data (CMS), all states. 3 of the 6 listed Romiplostim Injection NDCs had Medicaid claims.
Compare Romiplostim Injection Products
A representative set of FDA-listed product records for Romiplostim Injection — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Injection | ||||
| 125 mcg/0.25 mL | Subcutaneous | Amgen, Inc | BLA | View NDC → |
| 250 mcg/0.5 mL | Subcutaneous | Amgen, Inc | BLA | View NDC → |
| 500 mcg/mL | Subcutaneous | Amgen, Inc | BLA | View NDC → |
Showing 3 of 3 products — FDA National Drug Code Directory. See every product, package size and price: browse all 3 Romiplostim Injection NDCs →
Romiplostim Injection Side Effects Reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Romiplostim Injection — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Romiplostim Injection in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Romiplostim Injection FDA Approval History
How Romiplostim Injection went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
Romiplostim Injection Recall History
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list no Romiplostim recalls since July 2021.
✅No Romiplostim recalls on record since July 2021Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.
Romiplostim Injection in RxNorm: From Ingredient to Every Form and Strength
RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one ingredient (IN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. Combination products are separate concepts with their own pages.
- Dose forms
- 1
- Strengths
- 3
- Forms in current FDA listings
- 1 of 1
RxCUI 805452 RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
Romiplostim Injection Supply and Shortage Status
Whether Romiplostim Injection is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
Romiplostim Injection Brand Names
Romiplostim Injection has one brand name on record: Nplate. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.
Who Makes Romiplostim Injection: Manufacturers and Labelers
One company lists Romiplostim Injection products with the FDA. By number of product records, the largest are Amgen, Inc. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.
Sources for This Romiplostim Injection Page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Amgen Inc is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →